![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Applications:
Ingredient(s): METHACRYLIC ACID COPOLYMER TYPE A
Category: Controlled & Modified Release, Solubilizers
Technical Specifications: Available as powder; Other grades- EUDRAGIT® L 12,5
Applications:
Ingredient(s): Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form: Tablet
Category: Coating Systems & Additives, Controlled & Modified Release
Technical Specifications: Not Available
Applications:
Ingredient(s): Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form: Tablet
Category: Coating Systems & Additives, Controlled & Modified Release
Technical Specifications: Not Available
Applications:
It provides enteric protection at minimum weight gain, typically between 6.5 and 8.0%.
Ingredient(s): METHACRYLIC ACID COPOLYMER TYPE A
Dosage Form: Tablet
Category: Coating Systems & Additives
Technical Specifications: Not Available
Applications:
Ingredient(s): METHACRYLIC ACID COPOLYMER TYPE A
Dosage Form: Tablet
Category: Coating Systems & Additives
Technical Specifications: Not Available
Applications:
Enteric Coating (Drug delivery in Jejunum)
Ingredient(s): Methacrylic Acid - Methyl Methacrylate Copolymer (1:1) Type A
Category: Coating Systems & Additives
Technical Specifications: Not Available